Effect of feeding a low-vitamin A diet on carcass and production characteristics of steers with a high or low propensity for marbling.

Our research group demonstrated that vitamin A restriction affected meat quality of Angus cross and Simmental steers. Therefore, the aim of this study is to highlight the genotype variations in response to dietary vitamin A levels. Commercial Angus and Simmental steers (n = 32 per breed; initial BW = 337.2 ± 5.9 kg; ~8 months of age) were fed a low-vitamin A (LVA) (1017 IU/kg DM) backgrounding diet for 95 days to reduce hepatic vitamin A stores. During finishing, steers were randomly assigned to treatments in a 2 × 2 factorial arrangement of genotype × dietary vitamin A concentration. The LVA treatment was a finishing diet with no supplemental vitamin A (723 IU vitamin A/kg DM); the control (CON) was the LVA diet plus supplementation with 2200 IU vitamin A/kg DM. Blood samples were collected at three time points throughout the study to analyze serum retinol concentration. At the completion of finishing, steers were slaughtered at a commercial abattoir. Meat characteristics assessed were intramuscular fat concentration, color, Warner-Bratzler shear force, cook loss and pH. Camera image analysis was used for determination of marbling, 12th rib back fat and longissimus muscle area (LMA). The LVA steers had lower (P < 0.001) serum retinol concentration than CON steers. The LVA treatment resulted in greater (P = 0.03) average daily gain than the CON treatment, 1.52 and 1.44 ± 0.03 kg/day, respectively; however, there was no effect of treatment on final BW, DM intake or feed efficiency. Cooking loss and yield grade were greater and LMA was smaller in LVA steers (P < 0.05). There was an interaction between breed and treatment for marbling score (P = 0.01) and percentage of carcasses grading United States Department of Agriculture (USDA) Prime (P = 0.02). For Angus steers, LVA treatment resulted in a 16% greater marbling score than CON (683 and 570 ± 40, respectively) and 27% of LVA Angus steers graded USDA Prime compared with 0% for CON. Conversely, there was no difference in marbling score or USDA Quality Grades between LVA and CON for Simmental steers. In conclusion, feeding a LVA diet during finishing increased marbling in Angus but not in Simmental steers. Reducing the vitamin A level of finishing diets fed to cattle with a high propensity to marble, such as Angus, has the potential to increase economically important traits such as marbling and quality grade without negatively impacting gain : feed or yield grade.

Sleep spindles in bipolar disorder - a comparison to healthy control subjects.

OBJECTIVE: Bipolar disorder is a severe mental disorder for which currently no reliable biomarkers exist. It has been shown that patients with schizophrenia but not with unipolar depression have a reduced density of fast sleep spindles during N2 sleep. The aim of this study was to assess fast sleep spindle density in euthymic patients with bipolar disorder. METHODS: Patients with bipolar disorder (n = 24) and healthy control subjects (n = 25) were assessed using all-night polysomnography. Sleep spindles within stage N2 sleep were identified by visual inspection and subdivided into fast (>13 Hz) and slow (≤13 Hz) spindles. All spindles were subsequently characterised by density, frequency, amplitude, duration and coherence. RESULTS: Euthymic patients with bipolar disorder were found to have a reduced density and a lower mean frequency of fast spindles. Slow spindle density and frequency did not differ between groups. There were no differences regarding amplitude, duration or coherence. CONCLUSIONS: A reduction in fast spindle density during N2 sleep points towards thalamic dysfunction as a potential neurobiological mechanism of relevance in bipolar disorder. In addition, a reduced sleep spindle density could be interpreted as a common endophenotype shared with schizophrenia but not unipolar depression and may - if replicated - be of utility in early recognition and risk stratification.

Direct effect of pholyphenol-rich plants, rooibos and ginkgo, on porcine ovarian cell functions.

The polyphenol-rich plants rooibos and ginkgo are widely used in folk medicine and in preparation of foods and drinks, but their effect on reproduction has not been properly studied yet. The aim of our in vitro experiments was to examine the possible direct effect of rooibos and ginkgo on the basic ovarian cell functions-proliferation, apoptosis and release of hormones progesterone (P4) and leptin (L). Porcine ovarian granulosa cells were cultured in the presence of rooibos or ginkgo extract (0, 1, 10 and 100 µg/ml of medium). The accumulation of markers of proliferation (PCNA and cyclin B1) and apoptosis (bax) and their mRNAs was analysed using immunocytochemistry and by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Release of P4 and L was evaluated by radioimmunoassay. It was observed that rooibos or ginkgo addition was able to inhibit proliferation (down-regulates PCNA, cyclin B1 and their mRNAs), to promote apoptosis (accumulation of bax) and to suppress both L and P4 release by ovarian cells. These data suggest a direct inhibitory (anti-proliferative, pro-apoptotic and hormone-suppressing) effect of polyphenol-containing plants rooibos and ginkgo on ovarian functions. The potential anti-reproductive effect of these medical plants is to be taken into account by their consumption.

Supplementation of corn dried distillers' grains plus solubles to gestating beef cows fed low-quality forage: II. Impacts on uterine blood flow, circulating estradiol-17ß and progesterone, and hepatic steroid metabolizing enzyme activity.

The objective of this study was to investigate the effects of supplementing dried distillers' grains plus solubles (DDGS) during late gestation on uterine blood flow (BF), circulating steroid hormones and hepatic steroid metabolizing enzymes, and calf and placental weights. Multiparous beef cows were randomly divided into a control group (CON; = 15) consuming a diet containing 90% corn stover and 10% corn silage (DM basis) for ad libitum intake and a treatment group (SUP; = 12) consuming the same diet and DDGS (0.3% of BW). Corn silage inclusion was increased to 30% as gestation progressed to meet increasing caloric requirements. Ipsilateral and contralateral uterine BF and cross-sectional area (CSA) of each uterine artery were measured by Doppler ultrasonography on d 180, 216, and 246 of pregnancy. Contralateral BF and CSA increased ( < 0.01) as gestation advanced. Ipsilateral BF and CSA was affected by a treatment × day of gestation interaction ( < 0.05). A main effect of treatment ( = 0.02) and day ( < 0.01) was observed for total BF; BF increased over time and SUP cows had greater BF than CON cows. Circulating concentrations of both progesterone (P4) and estradiol-17ß (E2) were affected by an interaction of treatment and day ( < 0.01). Concentrations of circulating E2 steadily increased throughout the study and were greater in CON cows than in SUP cows by d 242. Concentrations of P4 also increased over time; P4 of CON cows was greater than that of SUP cows by d 242. Uridine 5'-diphospho-glucuronosyltransferase (UGT) and cytochrome P450 1A (CYP1A) activity increased with advancing gestation ( < 0.01). There was greater UGT activity ( < 0.05) and a trend for greater CYP1A activity ( = 0.06) in SUP cows than in CON cows. Activity of cytochrome P450 3A was greater ( < 0.01) in SUP cows and decreased ( < 0.05) with advancing gestation. Supplementing DDGS to cows fed low-quality forage during late gestation increased uterine BF but decreased circulating E2 and P4 concentrations and altered hepatic steroid metabolizing enzyme activity. It was anticipated that enzyme activity would reflect circulating hormone levels; however, our data suggests the observed increases in BF are not driven by alterations in hormone concentration. Therefore, further research is warranted to elucidate the underlying mechanisms.

Supplementation of corn dried distillers grains plus solubles to gestating beef cows fed low-quality forage: I. Altered intake behavior, body condition, and reproduction.

To investigate the effects of corn dried distillers grains plus solubles (DDGS) supplementation to cows fed corn stover and silage during late gestation, 27 multiparous beef cows (674 ± 17 kg; BCS, 5.6 ± 0.1) were divided randomly into 2 pens equipped with electronic feeders. For 10 wk, both groups were fed the basal diet for ad libitum intake while 1 group was supplemented (SUP; = 12) with DDGS at 0.3% of BW (DM basis). Following parturition, all cows received the same diet for an additional 8 wk. During gestation, SUP cows gained BW ( < 0.01), and there was no change in BCS ( 0.79). Nonsupplemented (CON) cows tended to lose BW ( 0.06) and lost BCS ( < 0.01) during gestation. Supplemented cows consumed more forage ( 0.01) and total feed than CON cows. An interaction of treatment and day was observed for time spent consuming forage ( < 0.01); SUP cows consumed forage faster than CON cows ( ≤ 0.01) early in gestation. Control cows ate more meals than SUP cows ( = 0.06) from d 201 to 218 of gestation. Supplemented cows tended ( = 0.09) to consume larger meals than CON cows and spent more ( < 0.01) time eating than CON cows around d 240 of gestation. Calves born to SUP cows tended ( = 0.06) to be heavier than calves born to CON cows. During lactation, both groups gained ( < 0.01) BW. Body condition score was less ( < 0.05) in CON cows than it was in SUP cows at the end of the study. Dry matter intake during lactation increased ( < 0.01) over time but was not influenced ( = 0.44) by treatment. Supplemented cows spent more time ( < 0.01) eating than CON cows after wk 4 of lactation, and they ate faster than CON cows until wk 3 of lactation whereas CON cows ate faster than SUP cows after wk 6 of lactation ( 0.01). The number of meals increased with advancing lactation ( < 0.01) and CON cows averaged more meals daily than SUP cows ( = 0.01). Conversely, meal size decreased as lactation advanced ( < 0.01), and SUP cows consumed larger meals than CON cows ( = 0.05). Supplementation with DDGS during gestation influenced intake behavior during gestation and lactation as well as the maintenance of maternal BW and BCS and calf birth BW.

Effects of alternate day feeding of dried distiller's grains plus solubles in forage-fed steers on intake, ruminal fermentation and passage rates, and serum nonesterified fatty acid.

Four ruminally and duodenally cannulated Holstein steers (BW = 449 ± 7.3 kg) were used to examine the effects of feeding either dried distiller's grains plus solubles (DG) or grass hay on alternate days (every other day) on intake, ruminal fermentation and passage rates, and serum NEFA in forage-fed steers. Steers were assigned to 1 of 4 dietary treatments in a 4 × 4 Latin square: 1) only hay (CON), 2) hay and 0.4% of BW as DG DM daily (DG7), 3) hay daily and 0.8% BW DG every other day (DG2), and 4) alternate day feeding of hay and 0.8% of BW as DG (DGA). Treatment periods consisted of 13 d of adaptation and 8 d of collecting digesta and blood. Over the entire collection period, DMI was decreased ( = 0.004) for DGA compared with other treatments (13.0 ± 0.8, 12.7 ± 0.8, 13.3 ± 0.8, and 10.9 ± 0.8 kg/d for CON, DG7, DG2, and DGA, respectively). Immediately after feeding on days supplement was fed to DG2 and DGA (supplemented days [SUP]), ruminal pH of DGA was less than other treatments but by the end of the day was greater than other treatments (treatment × time, < 0.001). At feeding time on nonsupplemented days (NSUP), ruminal pH of DGA steers was greater than other treatments but was similar (treatment × time, < 0.001) to DG2 and CON by 5 h after feeding. Total concentrations of VFA were similar ( = 0.09) among treatments on SUP; however, on NSUP, total VFA concentrations were least in DGA from feeding until 4 h after feeding (treatment × time, = 0.02). No differences ( ≥ 0.06) were observed among treatments for apparent ruminal, total intestinal, and total tract DM, OM, or CP digestibility. There were no differences ( = 0.36) in serum NEFA among treatments on SUP; however, on NSUP, steers fed DGA (209.5 ± 12.7 m) had greater ( < 0.01) NEFA compared with other treatments (84.4 ± 12.7, 88.0 ± 12.7, and 77.7 ± 12.7 m for CON, DG7, and DG2, respectively). The DGA feeding strategy influenced DMI and ruminal kinetics and circulating NEFA without impacting total tract digestibility.

[Acute pain therapy in German hospitals as competitive factor. Do competition, ownership and case severity influence the practice of acute pain therapy?]. / Akutschmerztherapie in deutschen Krankenhäusern als Wettbewerbsfaktor. Wird die Praxis der Akutschmerztherapie von Wettbewerb, Trägerschaft und Fallschwere beeinflusst?

BACKGROUND: Due to the implementation of the diagnosis-related groups (DRG) system, the competitive pressure on German hospitals increased. In this context it has been shown that acute pain management offers economic benefits for hospitals. The aim of this study was to analyze the impact of the competitive situation, the ownership and the economic resources required on structures and processes for acute pain management. MATERIAL AND METHODS: A standardized questionnaire on structures and processes of acute pain management was mailed to the 885 directors of German departments of anesthesiology listed as members of the German Society of Anesthesiology and Intensive Care Medicine (DGAI, Deutsche Gesellschaft für Anästhesiologie und Intensivmedizin). RESULTS: For most hospitals a strong regional competition existed; however, this parameter affected neither the implementation of structures nor the recommended treatment processes for pain therapy. In contrast, a clear preference for hospitals in private ownership to use the benchmarking tool QUIPS (quality improvement in postoperative pain therapy) was found. These hospitals also presented information on coping with the management of pain in the corporate clinic mission statement more often and published information about the quality of acute pain management in the quality reports more frequently. No differences were found between hospitals with different forms of ownership in the implementation of acute pain services, quality circles, expert standard pain management and the implementation of recommended processes. Hospitals with a higher case mix index (CMI) had a certified acute pain management more often. The corporate mission statement of these hospitals also contained information on how to cope with pain, presentation of the quality of pain management in the quality report, implementation of quality circles and the implementation of the expert standard pain management more frequently. There were no differences in the frequency of using the benchmarking tool QUIPS or the implementation of recommended treatment processes with respect to the CMI. CONCLUSION: In this survey no effect of the competitive situation of hospitals on acute pain management could be demonstrated. Private ownership and a higher CMI were more often associated with structures of acute pain management which were publicly accessible in terms of hospital marketing.

Effect of flaxseed physical form on digestibility of lactation diets fed to Holstein steers.

Four multicannulated (rumen, duodenum, and ileum) Holstein steers (459.7±46.4kg of initial body weight) were used in a 4×4 Latin square design to determine the effect of flaxseed processing method on ruminal fermentation and digestibility. Treatments were based on inclusion of (1) 7.5% linseed meal (control), (2) 10% whole flaxseed, (3) 10% rolled flaxseed, or (4) 10% ground flaxseed on a dry matter (DM) basis, and were formulated to mimic typical high-producing dairy cow lactation diets. The control diet contained linseed meal in a proportion to provide crude protein (CP) equal to the amount of CP contributed by the flaxseed in the other treatments. Diets were fed for ad libitum intake and contained 30% corn silage, 17% chopped alfalfa hay, 6% sugar beet pulp, and 47% concentrate (comprising ground corn, supplemental protein, trace minerals and vitamins, and either flaxseed or linseed meal (DM basis). Diets were formulated to contain 17% CP, 34% neutral detergent fiber, 21% acid detergent fiber, and 4% fatty acid (DM basis). Periods were 14 d long and consisted of 7 d of adaptation and 7 d of sample collection. Dry matter intake (as a % of body weight) was similar (2.41±0.17) for all treatments. The inclusion of flaxseed, regardless of processing method, tended to decrease total-tract organic matter digestibility relative to the linseed control, but no differences in CP intake, duodenal CP flow (bacterial, apparent feed, or total), ileal CP flow, fecal CP output, microbial efficiency, or CP digestibility (apparent ruminal, true ruminal, small intestine, large intestine, or total tract) were observed between treatments. Method of processing did not alter ruminal pH, ammonia, or volatile fatty acids production. The ground flaxseed treatment had the fastest rate of in situ DM degradation (11.25%/h), followed by the control (7.46%/h), rolled flaxseed (4.53%/h), and whole flaxseed (0.57%/h) treatments. Degradability of CP and fat followed the same pattern as DM degradability for processed flaxseed. In situ degradation rates of alfalfa hay neutral detergent fiber and acid detergent fiber tended to be fastest for the ground flaxseed treatment. Taken together, the digestibility, fermentation, and in situ data indicate that rolling and grinding are both acceptable methods of processing flaxseed. The in situ data strongly support the need for processing flaxseed before inclusion in lactation diets.

Effects of alternate-day feeding of dried distiller's grain plus solubles to forage-fed beef cows in mid- to late gestation.

Forty-six nonlactating beef cows were used to examine effects of dried distiller's grains plus solubles (DG) supplementation strategies to cows fed grass hay during mid- to late gestation on BW, ultrasound body composition characteristics, concentrations of serum NEFA and urea, feeding behavior, and calf birth weight. Cows were assigned to dietary treatments in a completely randomized design: 1) control, where hay was fed each day of the week (CON), 2) both hay and DG fed daily during the week (DG7), 3) hay fed daily but DG fed 3 d of the week (DG3), and 4) hay fed 4 d of the week alternating with DG fed on the remaining 3 d (DGA). Hay was offered ad libitum on days it was fed. The DG were fed at 0.40% of BW when offered daily and 0.93% of BW when offered 3 d per week (Monday, Wednesday, and Friday). Feed intake was monitored continuously over the 84-d feeding period. Hay intake and total DMI were reduced (P < 0.05) in DGA compared with DG7 and DG3. Gain and G:F were decreased (P < 0.05) for CON compared with other treatments. No differences (P > 0.05) were observed among treatments for change in BCS, intramuscular fat, rib fat, or rump fat from d 1 to 84. On a day when DG7, DG3, and DGA all received DG (Friday), DGA had reduced (P < 0.05) concentrations of urea compared with DG3 and DG7. On a day when only DG7 received DG (Saturday), urea was greater (P < 0.01) for DG3 and DGA compared with DG7, and concentrations of NEFA were greater (P < 0.01) in CON and DGA compared with DG7. On the second consecutive day when only DG7 received DG (Sunday), concentrations of NEFA were less (P < 0.001) for DG7 compared with other treatments. On days when all cows received hay, DGA spent more time eating (P < 0.05) compared with DG7 and DG3. Cows fed DGA had greater (P < 0.05) hay intake per meal and time per meal compared with other treatments. On days when DG7, DG3, and DGA all received DG, cows in the DG3 and DGA treatments had greater (P < 0.05) number of DG meals, time spent eating, intake per meal, and time per meal but a slower (P < 0.05) rate of DG intake compared with DG7. No differences (P > 0.05) were observed in calf birth weights among treatments. The alternate-day feeding strategy reduced hay and total intake, altered concentrations of serum urea and NEFA, and altered feeding behavior compared with other supplementation methods.

Effects of zoledronic acid on bone mineral density in premenopausal women receiving neoadjuvant or adjuvant therapies for HR+ breast cancer: the ProBONE II study.

UNLABELLED: The effects of bisphosphonates on altered bone turnover marker (BTM) levels associated with adjuvant endocrine or chemotherapy in early breast cancer have not been systematically investigated. In ProBONE II, zoledronic acid decreased these elevated BTM levels and increased bone mineral density (BMD) during adjuvant therapy, consistent with its antiresorptive effects. INTRODUCTION: Adjuvant chemotherapy or endocrine therapy for early hormone receptor-positive breast cancer (HR(+) BC) is associated with rapid BMD loss and altered BTM levels. Adjuvant bisphosphonate studies demonstrated BMD increases, but did not investigate BTM effects. The randomized, double-blind, ProBONE II study investigated the effect of adjuvant zoledronic acid (ZOL) on BMD and BTM in premenopausal women with early HR(+) BC. METHODS: Seventy premenopausal women with early HR(+) BC received adjuvant chemotherapy and/or endocrine therapy plus ZOL (4 mg IV every 3 months) or placebo for 24 months. Primary endpoint was change in lumbar spine BMD at 24 months versus baseline. Secondary endpoints included femoral neck and total femoral BMD changes, changes in BTM, and safety. RESULTS: Lumbar spine BMD increased 3.14% from baseline to 24 months in ZOL-treated participants versus a 6.43% decrease in placebo-treated participants (P < 0.0001). Mean changes in T- and Z-scores, and femoral neck and total femoral BMD, showed similar results. Bone resorption marker levels decreased ∼ 55% in ZOL-treated participants versus increases up to 65% in placebo-treated participants (P < 0.0001 for between-group differences). Bone formation marker (procollagen I N-terminal propeptide) levels decreased ∼ 57% in ZOL-treated participants versus increases up to 45% in placebo-treated participants (P < 0.0001 for between-group differences). Adverse events were consistent with the established ZOL safety profile and included one case of osteonecrosis of the jaw after a tooth extraction. CONCLUSIONS: Adding ZOL to adjuvant therapy improved BMD, reduced BTM levels, and was well tolerated in premenopausal women with early HR(+) BC receiving adjuvant chemotherapy and/or endocrine therapy.

Influence of supplementation with corn dried distillers grains plus solubles to growing calves fed medium-quality hay on growth performance and feeding behavior.

To determine the effect of increasing supplementation of corn dried distillers grains plus solubles (DDGS) on growth performance and feeding behavior, 70 steer calves (287 ± 10 kg of BW) were blocked by BW to 3 pens equipped with Insentec feeders. For 84 d, calves were fed medium-quality grass/legume hay offered for ad libitum intake and provided 1 of 3 dietary supplemental treatments (n = 7 or 8 steers per treatment within each pen; n = 23 or 24 per treatment): 1) nothing, 2) DDGS at 0.5% of BW daily (DM basis), and 3) DDGS at 1% of BW daily (DM basis). Hay intake (kg/d and % of BW daily) decreased linearly (P < 0.001) as DDGS supplementation increased. Total DMI (kg/d and % of BW) increased linearly (P < 0.001) with DDGS supplementation. Average daily gain and gain efficiency (G:F) responded quadratically (P ≤ 0.006) as G:F increased to a lesser extent when DDGS supplementation increased from 0.5 to 1% than from 0 to 0.5%. Meals (number per day) and time eating per meal for hay and total diet decreased linearly (P ≤ 0.006) with increasing DDGS supplementation. Time eating per day for hay responded quadratically (P < 0.001) and decreased to a greater extent when increasing from 0 to 0.5% DDGS supplementation than from 0.5 to 1% DDGS. Feed intake per minute (eating rate) for hay and total diet increased linearly (P ≤ 0.05) with increasing DDGS supplementation. On d 84, LM area, back fat thickness, and rump fat thickness increased linearly (P ≤ 0.006) with increasing DDGS supplementation. There were significant day × treatment interactions (P < 0.001) for plasma glucose and urea-N concentrations. Glucose did not change over the feeding period in control steers but increased in both supplemented groups. Urea-N decreased for control steers over the feeding period whereas urea-N increased in supplemented steers. In conclusion, supplementation of DDGS in amounts of 0.5 or 1% of BW daily can be used to reduce hay intake and improve ADG and G:F in growing steers fed medium-quality hay. Additionally, DDGS supplementation alters feeding behavior.

Influence of nitrogen and sulfur intake on bovine uterine pH throughout the luteal phase.

Previous research has reported that diets high in protein and sulfur decreased uterine pH in cattle. The objective of this study was to determine the effect of high N and high S intake on uterine pH. Holstein (n = 15) and Angus-cross (n = 5) heifers (337.5 ± 8.4 kg of BW) were randomly assigned to 1 of 4 diets: control (CON; 13.4% CP and 0.17% S); high nitrogen (HN; CON plus urea supplement); high sulfur (HS; CON plus calcium sulfate); or both high nitrogen and sulfur (HNS). Diets were individually fed at 2.6% of BW on a DM basis using Calan gates and estrus was synchronized to occur on d 13 (d 0 = start of dietary treatment). Blood samples were collected on d -2 and daily (d 1 to 28) at 1400 h to determine concentrations of plasma urea nitrogen (PUN), sulfate (d 1, 4, 8, 12, 16, 20, 24, and 28), and progesterone. Uterine pH was measured on d 16, 20, 24, and 28 (d 3, 7, 11, and 15 of the estrous cycle). There was a treatment, time, and treatment by time interaction (P < 0.01) on concentrations of PUN. There was an effect of treatment (P < 0.01) on concentrations of sulfate, with concentrations being increased in HS compared with CON, HN, and HNS (P < 0.01), and HNS increased compared with CON (P < 0.01) and HN (P < 0.01). Uterine pH was increased in HN and HNS compared with CON (P < 0.02), whereas HS was not different from any treatment (P > 0.11). There was no effect of time (P = 0.26) or treatment by time interaction (P = 0.71) on uterine pH. In summary, uterine pH was increased in HN and HNS compared with CON, whereas HS was intermediate and was associated with increased concentrations of PUN.

Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study.

BACKGROUND: Vitamin D levels are known to be associated with atopic disease development; however, existing data are controversial. The aim of this study was to investigate whether corresponding maternal and cord blood vitamin D levels are associated with atopic outcomes in early infancy. METHODS: Within the LINA cohort study (Lifestyle and environmental factors and their Influence on Newborns Allergy risk), 25(OH)D was measured in blood samples of 378 mother-child pairs during pregnancy and at birth. Information about children's atopic manifestations during the first 2 years of life was obtained from questionnaires filled out by the parents during pregnancy and annually thereafter. Cord blood regulatory T cells (Treg) were detected by methylation-specific PCR using a Treg-specific demethylated region in the FOXP3 gene. RESULTS: The median maternal 25(OH)D(3) level was 22.19 ng/ml (IQR 14.40-31.19 ng/ml); the median cord blood 25(OH)D(3) 10.95 ng/ml (6.99-17.39 ng/ml). A high correlation was seen between maternal and cord blood 25(OH)D(3) levels, both showing a seasonal distribution. Maternal and cord blood 25(OH)D(3) was positively associated with children's risk for food allergy within the first 2 years. Further, higher maternal 25(OH)D(3) resulted in a higher risk for sensitization against food allergens at the age of two. Cord blood 25(OH)D(3) levels were negatively correlated with regulatory T cell numbers. CONCLUSION: Our study demonstrates that high vitamin D levels in pregnancy and at birth may contribute to a higher risk for food allergy and therefore argues against vitamin D supplement to protect against allergy.

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer.

Postmenopausal women have an increased risk of osteopenia and osteoporosis due to loss of the bone-protective effects of estrogen. Disease-related processes may also contribute to the risk of bone loss in postmenopausal women with breast cancer. One of the most common and severe safety issues associated with cancer therapy for patients with breast cancer is bone loss and the associated increase in risk of fractures. This paper reviews the recent literature pertaining to aromatase inhibitor (AI)-associated bone loss, and discusses suggested management and preventative approaches that may help patients remain on therapy to derive maximum clinical benefit. A case study is presented to illustrate the discussion. We observed that AIs are in widespread use for women with hormone receptor-positive breast cancer and are now recommended as adjuvant therapy, either as primary therapy or sequential to tamoxifen, for postmenopausal women. AIs target the estrogen biosynthetic pathway and deprive tumor cells of the growth-promoting effects of estrogen, and AI therapies provide benefits to patients in terms of improved disease-free survival. However, there is a concern regarding the increased risk of bone loss with prolonged AI therapy, which can be managed in many cases with the use of bisphosphonates and other interventions (eg, calcium, vitamin D supplementation, exercise).

Neuroprotective effects of a new skin care formulation following ultraviolet exposure.

BACKGROUND: Chronic ultraviolet (UV) exposure is a major environmental factor involved in extrinsic skin ageing (photo-ageing). Skin nerve fibres are significantly reduced in number following UV irradiation and new skincare compounds with neuroprotective effects are thus highly warranted. OBJECTIVES: We developed a new skincare formulation from a plant extract and evaluated its neuroprotective effects of ex vivo UV irradiation. MATERIALS AND METHODS: The new skincare emulsion was formulated from Echinacea purpurea extract and was enriched with antioxidants (patent no. PROV020110087075). Skin samples were obtained from 20 healthy patients enrolled for plastic surgery and were immediately treated with placebo (SPF 15) or test emulsions. Skin samples were exposed to UVA and UVB for 60 min. Nerve fibres were identified by immunofluorescence using a monoclonal antibody, anti-human CD56. Cell damage was quantified by image analysis. RESULTS: UVA and UVB significantly reduced (40-60%) densities of nerve endings in control samples treated with placebo (P < 0.001). Samples treated with test emulsion completely blocked UV-related effects on skin nerve endings. These neuroprotective effects were similarly observed regardless of age or tissue analysed (breast versus abdomen). CONCLUSIONS: Our new skincare formulation obtained from E. purpurea provides important neuroprotective effects of UV irradiation and could be used together with SPFs to prevent chronic deleterious effects of solar exposure.

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Testing of Cryptococcus neoformans for susceptibility to antifungal drugs by standard microtiter methods has not been shown to correlate with clinical outcomes. This report describes a modified quantitative broth macrodilution susceptibility method showing a correlation with both the patient's quantitative biological response in the cerebrospinal fluid (CSF) and the survival of 85 patients treated with amphotericin B (AMB). The Spearman rank correlation between the quantitative in vitro measure of susceptibility and the quantitative measure of the number of organisms in the patient's CSF was 0.37 (P < 0.01; 95% confidence interval [95% CI], 0.20, 0.60) for the first susceptibility test replicate and 0.46 (P < 0.001; 95% CI, 0.21, 0.62) for the second susceptibility test replicate. The median in vitro estimated response (defined as the fungal burden after AMB treatment) at 1.5 mg/liter AMB for patients alive at day 14 was 5 CFU (95% CI, 3, 8), compared to 57 CFU (95% CI, 4, 832) for those who died before day 14. These exploratory results suggest that patients whose isolates show a quantitative in vitro susceptibility response below 10 CFU/ml were more likely to survive beyond day 14.

Measuring and modeling of binary mixture effects of pharmaceuticals and nickel on cell viability/cytotoxicity in the human hepatoma derived cell line HepG2.

The interaction of drugs and non-therapeutic xenobiotics constitutes a central role in human health risk assessment. Still, available data are rare. Two different models have been established to predict mixture toxicity from single dose data, namely, the concentration addition (CA) and independent action (IA) model. However, chemicals can also act synergistic or antagonistic or in dose level deviation, or in a dose ratio dependent deviation. In the present study we used the MIXTOX model (EU project ENV4-CT97-0507), which incorporates these algorithms, to assess effects of the binary mixtures in the human hepatoma cell line HepG2. These cells possess a liver-like enzyme pattern and a variety of xenobiotic-metabolizing enzymes (phases I and II). We tested binary mixtures of the metal nickel, the anti-inflammatory drug diclofenac, and the antibiotic agent irgasan and compared the experimental data to the mathematical models. Cell viability was determined by three different methods the MTT-, AlamarBlue(R) and NRU assay. The compounds were tested separately and in combinations. We could show that the metal nickel is the dominant component in the mixture, affecting an antagonism at low-dose levels and a synergism at high-dose levels in combination with diclofenac or irgasan, when using the NRU and the AlamarBlue assay. The dose-response surface of irgasan and diclofenac indicated a concentration addition. The experimental data could be described by the algorithms with a regression of up to 90%, revealing the HepG2 cell line and the MIXTOX model as valuable tool for risk assessment of binary mixtures for cytotoxic endpoints. However the model failed to predict a specific mode of action, the CYP1A1 enzyme activity.

Effect of selenium supplementation and plane of nutrition on mares and their foals: foaling data.

To investigate the maternal plane of nutrition and role of Se yeast on foaling variables and passive transfer of IgG, 28 Quarter Horse mares were used in a study with a randomized complete block design. Mares were blocked by expected foaling date and assigned randomly within block to dietary treatments. Dietary treatments were arranged as a 2 x 2 factorial with 2 planes of nutrition, pasture or pasture + grain mix (fed at 0.75% of BW on an as-fed basis) and 2 concentrations of Se yeast (0 or 0.3 mg/kg of DMI). This resulted in 4 treatments: pasture (PA), pasture + Se (PS), pasture + grain mix (PG), and pasture + grain mix + Se (PGS). Assuming DMI at 2% of BW, the mares fed PA and PS received approximately 100% of the calculated NRC (2007) DE requirements, whereas PG and PGS received 120%. Selenium supplementation began 110 d before the estimated foaling date, and all dietary treatments were terminated at parturition. At parturition, foaling variables were recorded. Additionally, placental weight was recorded and 2 samples from each placenta were collected for analysis of DNA, RNA, and protein. Colostrum was obtained for fat, protein, milk urea N, somatic cell count, and IgG analyses. Foal blood samples were collected at 0, 6, 12, 18, and 24 h after parturition for IgG analysis. There was no effect (P >or= 0.21) of Se or plane of nutrition on foaling variables; however, foal BW as a percentage of mare BW tended (P = 0.10) to be reduced in foals from mares on grain mix (PG and PGS; 7.6%) compared with mares not fed grain mix (PA and PS; 8.0%). There was also no effect (P >or= 0.20) of Se or plane of nutrition on placental cell number (mg of DNA/g), potential cellular activity (RNA:DNA), expulsion time, or weight. However, mares fed supplemental Se (PS and PGS) had decreased (P = 0.02) placental cell size (24.1 mg of protein/mg of DNA) compared with mares not fed supplemental Se (PA and PG; 32.5 mg of protein/mg of DNA). There was also no effect (P >or= 0.18) of Se or plane of nutrition on colostral fat, protein, milk urea N, or somatic cell count. However, mares fed grain mix (PG and PGS) had less (P = 0.03) colostral IgG (76.5 g/L) compared with mares not fed grain mix (PA and PS; 126.6 g/L). Foals from mares fed grain (PG and PGS) tended (P = 0.06) to have less overall serum IgG (13.6 g/L) compared with foals from mares not fed grain (PA and PS; 15.3 g/L). These data indicate that the maternal diet during the last one-third of gestation affects placental efficiency and colostral IgG.

Effects of distillers dried grains with solubles on growing and finishing steer intake, performance, carcass characteristics, and steak color and sensory attributes.

Seventy-two crossbred and purebred beef steers (296 +/- 9 kg initial BW) were used in a completely randomized design to determine effects of 30% distillers dried grains with solubles (DDGS; 29.2% CP, 9.7% fat, DM basis) inclusion during the growing or finishing period on DMI, performance, carcass, and meat quality traits. The resulting treatments were 0:0, 30:0, 0:30, and 30:30 (diet DDGS percentage fed during growing and finishing periods, respectively). Steers were individually fed a growing diet (65% concentrate) for 57 d, then acclimated to and fed a finishing diet (90% concentrate) for 80 or 145 d. Dietary ingredients included dry-rolled corn, corn silage, grass hay, concentrated separator by-product, and supplement. Diets included 27.5 mg/kg of monensin and 11 mg/kg of tylosin and were formulated to contain a minimum of 12.5% CP, 0.70% Ca, and 0.30% P. During the growing period, DMI was not different (P >or= 0.63; 10.22 +/- 0.23 kg/d; 2.42 +/- 0.06% of BW). Steer performance, including ADG (1.75 +/- 0.05 kg/d) and G:F (174.1 +/- 6.8 g/kg), was not affected (P >or= 0.14) by treatment during the growing period, and final BW at the end of the growing period was not different (425 +/- 7 kg; P = 0.99). During the finishing period, DMI was not different (P >or= 0.54; 8.47 +/- 0.66 kg/d; 1.57 +/- 0.09% BW). During the finishing period, no differences (P >or= 0.22) were observed for ADG (1.54 +/- 0.07 kg/d) or G:F (202.4 +/- 28.3 g/kg). As a result, final BW was not different (P >or= 0.28; 551 +/- 15 kg). Longissimus muscle area (77.8 +/- 3.3 cm(2)), 12th-rib fat thickness (1.26 +/- 0.10 cm), and KPH (2.48 +/- 0.16%) were not different (P >or= 0.16). There were no differences (P >or= 0.35) in yield grade (3.33 +/- 0.17) or marbling (431 +/- 21; Small(0) = 400). Results from the trained panel indicated no differences (P >or= 0.16) in tenderness, which averaged 6.03 +/- 0.16 (8-point hedonic scale); however, steaks from steers fed 0:30 or 30:30 tended (P = 0.10) to be juicier and more flavorful than steaks from steers fed 0:0 or 30:0 (6.01 vs. 5.83 +/- 0.11; 6.02 vs. 5.89 +/- 0.08, respectively). Inclusion of 30% DDGS in the growing period tended to reduce L (P = 0.08; 48.6 vs. 48.9 +/- 0.2) and b (P = 0.01; 8.24 vs. 8.65 +/- 0.18) of steaks. Feeding DDGS during growing or finishing reduced b (P = 0.02; 8.35 vs. 8.74 +/- 0.18) compared with 0:0. Feeding DDGS during the finishing period reduced a (P < 0.001; 20.1 vs. 22.0 +/- 0.24) of steaks. Furthermore, feeding DDGS during growing or finishing reduced a (P < 0.001; 20.9 vs. 21.7 +/- 0.24) compared with 0:0. Feeding 30% DDGS did not affect any performance or carcass characteristics but did influence steak sensory attributes and color.

[The gynecological TURP syndrome. Severe hyponatremia and pulmonary edema during hysteroscopy]. / Das gynäkologische "TUR-Syndrom". Schwere Hyponatriämie und Lungenödem während operativer Hysteroskopie.

Fluid overload and dilutional hyponatremia are rare but typical complications of endoscopic transurethral resection of the prostate gland (TURP syndrome). Less commonly, this complication caused by excessive absorption of hypotonic, electrolyte-free non-conductive distention solution, may also occur during endoscopic surgery of the uterus, e.g. operative hysteroscopy. A case report is presented of a 44-year-old woman scheduled for operative hysteroscopy for intracavital myoma under general anaesthesia, suffering from severe absorption syndrome leading to hyponatremia of 106 mEq/l and pulmonary edema necessitating subsequent admission to ICU. Anatomical and physiological as well as technical aspects of this syndrome are discussed. Recommendations for anesthesiology management are offered and a possible treatment of acute hyponatremia is discussed.